Global Regulatory Outlook for CRISPRized Plants (Genome Modified Plants and Microbes in Food and Agriculture) - Softcover

 
9780443184444: Global Regulatory Outlook for CRISPRized Plants (Genome Modified Plants and Microbes in Food and Agriculture)

Inhaltsangabe

Global Regulatory Outlook of CRISPRized Plants summarizes CRISPR/Cas systems and applications for precise editing of plant genomes and discusses global regulatory frameworks for CRISPR edited crops. While CRISPR technology has become a routine, cheap, and efficient method to generate edited crops with superior traits, how these crops are regulated determines the future of this technology. Understanding the current state of regulation, concerns, issues, and foundations for future decisions are key in determining how this technology is used going forward. This important summary will be vital to the successful commercialization of CRISPR technology and biosafety concerns associated with this technology. The book highlights regulatory classification of CRISPR modifications such as SDN1, SDN2 and SDN3 and their global regulation and discusses the social, ethical, governance, and policy issues related to CRISPR edited crops.

  • Presents regulatory frameworks for CRISPR edited crops in the USA, Canada, Australia and New Zealand, Japan, EU, Africa, and Asia
  • Includes a specific chapter on global regulation of genetically engineered crops
  • Addresses public perception, social aspects, and ethical concerns that are impacting the commercialization of CRISPR edited crops

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Über die Autorinnen und Autoren

Prof. Kamel A. Abd-Elsalam, Ph.D., is currently a research professor at the Plant Pathology Research Institute, Agricultural Research Center, Giza. Kamel earned his Ph.D. in Molecular Plant Pathology from Christian Alberchts University of Kiel (Germany) and Suez Canal University (Egypt). Dr. Kamel’s research interests include developing, improving, and deploying plant biosecurity diagnostic tools; understanding and exploiting fungal pathogen genomes; and developing eco-friendly hybrid nanomaterials for controlling toxicogenic fungi, plant diseases, and agroecosystems applications. He published 20 books related to nano-biotechnology applications in agriculture and plant protection. Since 2019, he has served as the Editor-in-Chief of the Elsevier book series “Nanobiotechnology for Plant Protection.” He also serves as the Series Editor of the Elsevier book series “Genome Modified Plants and Microbes in Food and Agriculture.”

Dr Aftab Ahmad is currently working as Assistant Professor at Department of Biochemistry/ US-Pakistan Center for Advanced Studies in Agriculture and Food Security (CAS-AFS), University of Agriculture, Faisalabad (UAF), Pakistan. Dr Aftab’s research interests include developing virus resistant and salt tolerant plants using CRISPR/Cas technology. He has published more than 15 research articles in international peer reviewed journals including Journal of Biomedical Sciences, Scientific Reports-Nature, PLOS One, Journal of Translational Medicine, Plant Molecular Biology Reporter, Molecules, Journal of Cereal Science, and Genetic Resources and Crop Evolution. Dr Aftab pursued his PhD and postdocs in Plant Molecular Biology from University of Shizuoka, Japan under Center of Excellence (COE, 21st Century) program. Dr Aftab also served as visiting scientist in department of plant sciences, University of California, Davis, USA. Dr Aftab has been teaching biochemistry and molecular biology at UAF and his research focuses in the area of CRISPR/Cas based genome editing in plants.

Von der hinteren Coverseite

Global Regulatory Outlook of CRISPRized Plants summarizes CRISPR/Cas systems and applications for precise editing of plant genomes and discusses the global regulatory framework for CRISPR edited crops. While CRISPR technology has become a routine, cheap and an efficient method to generate edited crops with superior traits, how these crops will be regulated, will determine the future of this technology. Understanding the current state of regulation, the concerns, issues and foundations for decisions will be key in determining how this technology is used going forward.

A major challenge to the world community in the future will be keeping food and energy production in pace with the increasing world population and changing climate. To meet the 21st century population demands, world needs to grow crop varieties with high yield, drought, tolerance to heat and salt, and with better nutrition values and shelf life. Applications of CRISPR/Cas system toward both basic and applied problems in plant biology have become routine to address problems associated with plants. CRISPR/Cas is overcoming barriers and has potential to fulfill the early promises of genetic engineering such as plants with higher yield, better biotic and abiotic resistance and more nutritious food. It is likely that CRISPR technologies will continue to evolve and CRISPR crops will play a major role in future food security of the world.

CRISPR/Cas technology has been extensively demonstrated for efficient and precise genome editing of model and crop plants for a broad range of applications. In addition, DNA free editing with CRISPR/Cas has made possible to produce plants which are indistinguishable from plants produced with conventional breeding. Although CRISPR holds a tremendous potential rewrite genomic landscape of crop genome, off-targets and efficient delivery of CRISPR reagents are major challenges in translational applications. Further commercialization of CRISPR crops bypassing regulatory frameworks for GMOs in some countries have started a global debate about regulate however still debate persist how to regulate these crops.

Global Regulatory Outlook of CRISPRized Plants highlights regulatory classification of CRISPR modifications such as SDN1, SDN2 and SDN3 and their global regulation. and discusses the social, ethical, governance, and policy issues related to CRISPR edited crops. This important summary will be vital to the successful commercialization of CRISPR technology and biosafety concerns associated with this technology.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.